JH-VIII-157-02

JH-VIII-157-02 Suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ:65489617 13301690235
Email: Sales@ATKchemical.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: HANGZHOU CLAP TECHNOLOGY CO.,LTD  
Tel: 86-571-88216897,88216896 13588875226
Email: sales@hzclap.com
Company Name: Shanghai Star Pharmaceutical Chemical Technology Co., Ltd.  
Tel: 021-58521787 17701827760
Email: starpharmsh@gmail.com

JH-VIII-157-02 manufacturers

  • JH-VIII-157-02
  • JH-VIII-157-02 pictures
  • $118.00
  • 2026-07-14
  • CAS:1639422-97-1
  • Purity: 99.58%
  • Supply Ability: 10g
JH-VIII-157-02 Basic information
Product Name:JH-VIII-157-02
Synonyms:JH-VIII-157-02;1H-Pyrazole-1-acetamide, 4-(3-cyano-9-ethyl-6,11-dihydro-6,6-dimethyl-11-oxo-5H-benzo[b]carbazol-8-yl)-N,N-dimethyl-;JH-VIII-157-02, 10 mM in DMSO;CD246,Cluster of differentiation 246,inhibit,Anaplastic lymphoma kinase,Anaplastic lymphoma kinase (ALK),ALK tyrosine kinase receptor,Inhibitor,JHVIII15702,JH VIII 157 02;2-(4-(3-Cyano-9-ethyl-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazol-8-yl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide
CAS:1639422-97-1
MF:C28H27N5O2
MW:465.55
EINECS:
Product Categories:
Mol File:1639422-97-1.mol
JH-VIII-157-02 Structure
JH-VIII-157-02 Chemical Properties
Boiling point 751.9±60.0 °C(Predicted)
density 1.28±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : ≥ 25 mg/mL (53.70 mM)
pka13.70±0.40(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
JH-VIII-157-02 Usage And Synthesis
UsesJH-VIII-157-02 is a structural analogue of alectinib, acts as an ALK inhibitor, and shows an IC50 of 2 nM for echinoderm microtubule-associated protein-like 4-ALK (EML4-ALK) G1202R in cells.
Biological ActivityJH-VIII-157-02, a structural analog of alectinib, is an ALK inhibitor with IC50 of 2 nM for echinoderms microtubule-associated protein-like 4 (EML4)-ALK G1202R.
in vivo

JH-VIII-157-02 exhibits good oral bioavailability following an oral dose of 10 mg/kg in mice. JH-VIII-157-02 also penetrates the CNS of mice.

target

IC50: 2 nM (EML4-ALK G1202R, cell assay), 2 nM (EML4-ALK wt , cell assay), 2 nM (EML4-ALK C1156Y, cell assay) , 2 nM (EML4-ALK F1174L, cell assay), 2 nM (EML4-ALK F1174L, cell assay)

References[1] Hatcher JM, et al. Discovery of Inhibitors That Overcome the G1202R Anaplastic Lymphoma Kinase Resistance Mutation. J Med Chem. 2015 Dec 10;58(23):9296-9308. DOI:10.1021/acs.jmedchem.5b01136
JH-VIII-157-02 Preparation Products And Raw materials
Tag:JH-VIII-157-02(1639422-97-1) Related Product Information
1H-Pyrazole-3-carboxylic acid, 5-hydroxy-1-[3-(trifluoromethyl)phenyl]- Lorlatinib ALK/IGF1R inhibitor Methanone, (2,6-dimethyl-4-pyridinyl)[4-[7-(trans-4-hydroxycyclohexyl)-2-[[(1S)-1-methylbutyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-1-piperidinyl]- Brigatinib R-268712